Edwards Queeneth, Ayo-Farai Oluwatoyin, Uwumiro Fidelis E, Komolafe Babajide, Chibuzor Odigili E, Agu Ifeanyi, Nwuke Henry O, Uwaoma Gentle C, Amadi Emmanuel S, Enyi Marvis, Idahor Courage, Omeh Chinyere K
Internal Medicine, Georgia Southern University, Statesboro, Georgia, USA.
Epidemiology and Public Health, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, USA.
Cureus. 2025 Jan 24;17(1):e77941. doi: 10.7759/cureus.77941. eCollection 2025 Jan.
Background Data on trends in inflammatory bowel disease (IBD) hospitalizations in the literature are sparse and conflicting. This study evaluated trends in hospitalization and emergency department (ED) visits for IBD between 2010 and 2020 using large data from the United States national inpatient and emergency department sample databases. Methods We employed joinpoint regression analysis and Cuzick's tests to examine trends in hospitalizations, emergency department (ED) visits, and outcomes of hospitalization for IBD using nationwide inpatient and ED sample databases. Hospitalization costs were adjusted for inflation using the medical expenditure panel survey index. Results We analyzed 2,504,288 Crohn's Disease (CD) and 1,367,809 ulcerative colitis (UC) hospitalizations. There was an uptrend in the mean age of patients with IBD from 52.3 years in 2010 to 55.8 years in 2020 (P <0.001). Hospitalizations for IBD showed an upward trend with an average annual percent change (APC) of 0.92% (confidence interval [CI]: 0.67-1.17; P<0.001) and a marked increase in CD hospitalization until 2014 (APC, 2.16%; CI, 1.35-4.64; P=0.040). After 2014, CD hospitalizations showed a downward trend to 219,200 with an AAPC of -0.1% (CI: -1.79 to 1.61; P=0.890), whereas UC hospitalizations steadily increased over the decade (120,346 to 122,485; APC, 0.63%; CI, 0.52-0.74; P<0.001). Mortality rates increased by an average APC of 3.16% (P=0.002), especially among the middle-aged and older adults. Aggregate annual IBD hospitalization costs were $9.1 billion higher in 2020 than in 2010 (APC: 3.97% (CI: 2.98-4.97; P<0.001). There were 6,243,807 ED visits for IBDs over the study period. There was no significant change in the overall number of ED visits for IBD over the study period (574,038 to 448,647; APC: 0.1%; CI: -0.42 to 0.54; P=0.792). There was an uptrend in the total number of in-hospital procedures for IBD (622,647 to 642,210; APC: 0.64%; CI: 0.35-0.93; P=0.001). There was an uptrend in the incidence of combined incidences of malnutrition, anemia, bowel perforations, fistulae, and critical care admission for IBD (P for all < 0.001). Conclusion IBD hospitalization rates have increased with aging patient demographics, rising mortality rates, and increased healthcare spending over the past decade.
文献中关于炎症性肠病(IBD)住院趋势的数据稀少且相互矛盾。本研究利用美国国家住院患者和急诊科样本数据库的大数据,评估了2010年至2020年期间IBD的住院和急诊科就诊趋势。方法:我们采用连接点回归分析和库齐克检验,利用全国住院患者和急诊科样本数据库,研究IBD的住院、急诊科就诊及住院结局趋势。住院费用使用医疗支出面板调查指数进行通胀调整。结果:我们分析了2504288例克罗恩病(CD)住院患者和1367809例溃疡性结肠炎(UC)住院患者。IBD患者的平均年龄呈上升趋势,从2010年的52.3岁升至2020年的55.8岁(P<0.001)。IBD住院呈上升趋势,平均年变化百分比(APC)为0.92%(置信区间[CI]:0.67 - 1.17;P<0.001),且CD住院在2014年前显著增加(APC,2.16%;CI,1.35 - 4.64;P = 0.040)。2014年后,CD住院呈下降趋势,降至219200例,AAPC为 - 0.1%(CI: - 1.79至1.61;P = 0.890),而UC住院在这十年间稳步增加(从120346例增至122485例;APC,0.63%;CI,0.52 - 0.74;P<0.001)。死亡率平均APC增加3.16%(P = 0.002),尤其是在中年及老年人群中。2020年IBD住院总费用比2010年高出91亿美元(APC:3.97%(CI:2.98 - 4.97;P<0.001)。在研究期间,IBD的急诊科就诊次数为6243807次。研究期间IBD急诊科就诊总数无显著变化(从574038次降至448647次;APC:0.1%;CI: - 0.42至0.54;P = 0.792)。IBD住院期间的总手术数量呈上升趋势(从622647例增至642210例;APC:0.64%;CI:0.35 - 0.93;P = 0.001)。IBD合并营养不良、贫血、肠穿孔、瘘管及重症监护入院的发生率呈上升趋势(所有P<0.001)。结论:在过去十年中,随着患者人口老龄化、死亡率上升以及医疗保健支出增加,IBD住院率有所上升。